FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Olivier Tribut

Research Profile

Procedures

Chemicals & Drugs

Disorders

Physiology

Geographic Areas

France

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Soloniaina Rakotondravelo; Olivier Tribut; Cédric Arvieux; Françoise Borsa-Lebas; Arnaud de la Blanchardière; Fanny Giroux; Guy Hue; Hélène Jantzem; Hélène Kerspern; Nathalie Massy; Ahmed Meskar; Christophe Michau; Yves Poinsignon; Elisabeth Polard; Pierre Tattevin
Complicated atazanavir-associated cholelithiasis: a report of 14 cases.
Danièle Bentue-Ferrer; Olivier Tribut; Marie-Clémence Verdier
[Therapeutic drug monitoring of ethosuximide].
Danièle Bentue-Ferrer; Marie-Clémence Verdier; Olivier Tribut
[Therapeutic drug monitoring of primidone and phenobarbital].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Olivier Tribut (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Soloniaina Rakotondravelo; Olivier Tribut; Cédric Arvieux; Françoise Borsa-Lebas; Arnaud de la Blanchardière; Fanny Giroux; Guy Hue; Hélène Jantzem; Hélène Kerspern; Nathalie Massy; Ahmed Meskar; Christophe Michau; Yves Poinsignon; Elisabeth Polard; Pierre Tattevin
Complicated atazanavir-associated cholelithiasis: a report of 14 cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(9):1270-2.
2012: Danièle Bentue-Ferrer; Olivier Tribut; Marie-Clémence Verdier
[Therapeutic drug monitoring of ethosuximide].
Thérapie 2012;67(4):391-6.
2012: Danièle Bentue-Ferrer; Marie-Clémence Verdier; Olivier Tribut
[Therapeutic drug monitoring of primidone and phenobarbital].
Thérapie 2012;67(4):381-90.
2012: Danièle Bentue-Ferrer; Olivier Tribut; Marie-Clémence Verdier
[Therapeutic drug monitoring of rufinamide].
Thérapie 2012;67(2):161-5.
2012: Marie-Clémence Verdier; Olivier Tribut; Danièle Bentue-Ferrer
[Therapeutic drug monitoring of stiripentol].
Thérapie 2012;67(2):157-60.
2012: Danièle Bentue-Ferrer; Olivier Tribut; Marie-Clémence Verdier
[Therapeutic drug monitoring of lacosamide].
Thérapie 2012;67(2):151-5.
2012: Eric Dailly; Guillaume Deslandes; Olivier Tribut; Marie-Clémence Verdier; Régis Bouquié; Danièle Bentue-Ferrer
[Level of evidence for therapeutic drug monitoring of ceftriaxone].
Thérapie 2012;67(2):145-9.
2011: M C Verdier; C Michelet; P Tattevin; Olivier Tribut; Danièle Bentue-Ferrer
Assessment of interindividual variability of plasma concentrations after administrazion of high doses of intravenous amoxicillin or cloxacillin in critically ill patients.
Journal of chemotherapy (Florence, Italy) 2011;23(5):277-81.
2011: Marie-Clémence Verdier; Yves Le Tulzo; Christian Michelet; Pierre Tattevin; Olivier Tribut; Danièle Bentué-Ferrer
Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring.
Antimicrobial agents and chemotherapy 2011;55(10):4873-9.
2011: Marie-Clémence Verdier; anne cady; Bastien Le Touvet; Yannick Mallédant; Philippe Seguin; Olivier Tribut
Ertapenem in plasma and peritoneal fluid from patients with severe intra-abdominal infections.
The Journal of antimicrobial chemotherapy 2011;66(8):1934-6.
2011: Marie-Clémence Verdier; Sophie Bodeau; Dorothée Rihouey; Olivier Tribut; Danièle Bentue-Ferrer
[Level of evidence for therapeutic drug monitoring of low dose methotrexate in inflammatory diseases].
Thérapie 2011;66(1):63-72.
2011: Marie-Clémence Verdier; Danièle Bentué-Ferrer; Olivier Tribut; Nicolas Collet; Matthieu Revest; Eric Bellissant
Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2011;49(1):69-75.
2010: Marie-Clémence Verdier; Danièle Bentué-Ferrer; Olivier Tribut; Eric Bellissant
Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2010;48(10):1515-22.
2010: Thibault Dolley-Hitze; Marie-Clémence Verdier; Olivier Tribut; Yves Le Tulzo; Sophie Marqué
Oseltamivir dose adjustment in an H1N1 patient requiring haemodialysis.
Intensive care medicine 2010;36(9):1618-9.
2010: Thomas Guimard; Matthieu Revest; Cédric Arvieux; Christian Michelet; Pierre Tattevin; Pierre-Yves DONNIO; Olivier Tribut
Failure of antibiotic-lock technique using daptomycin for subcutaneous injection ports in a patient on home parenteral nutrition.
The Journal of infection 2010;60(6):505-7.
2010: Danièle Bentué-Ferrer; Olivier Tribut; Marie-Clémence Verdier
[Therapeutic drug monitoring of valproate].
Thérapie 2010;65(3):233-40.
2010: Danièle Bentué-Ferrer; Olivier Tribut; Marie-Clémence Verdier; Danièle Debruyne
[Therapeutic drug monitoring of clobazam].
Thérapie 2010;65(3):225-31.
2010: Pierre Tattevin; Delphine Monnier; Olivier Tribut; Joelle Dulong; Nadège Bescher; Frederic Mourcin; Fabrice Uhel; Yves Le Tulzo; Karin Tarte
Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock.
The Journal of infectious diseases 2010;201(6):956-66.
2010: Olivier Tribut; Danièle Bentué-Ferrer; Marie-Clémence Verdier
[Therapeutic drug monitoring of gabapentin].
Thérapie 2010;65(1):57-60.
2010: Danièle Bentué-Ferrer; Olivier Tribut; Marie-Clémence Verdier
[Therapeutic drug monitoring of tiagabine].
Thérapie 2010;65(1):51-5.
2010: Danièle Bentué-Ferrer; Olivier Tribut; Marie-Clémence Verdier
[Therapeutic drug monitoring of pregabaline].
Thérapie 2010;65(1):47-9.
2010: Danièle Bentué-Ferrer; Olivier Tribut; Marie-Clémence Verdier
[Therapeutic drug monitoring of lamotrigine].
Thérapie 2010;65(1):39-46.
2010: Olivier Tribut; Danièle Bentué-Ferrer; Marie-Clémence Verdier
[Therapeutic drug monitoring of felbamate].
Thérapie 2010;65(1):35-8.
2010: Marie-Clémence Verdier; Danièle Bentué-Ferrer; Olivier Tribut
[Therapeutic drug monitoring of zonisamide].
Thérapie 2010;65(1):29-34.
2010: Danièle Bentué-Ferrer; Olivier Tribut; Marie-Clémence Verdier
[Therapeutic drug monitoring of vigabatrin].
Thérapie 2010;65(1):23-7.
2010: Danièle Bentué-Ferrer; Olivier Tribut; Marie-Clémence Verdier
[Therapeutic drug monitoring of topiramate].
Thérapie 2010;65(1):17-22.
2009: Danièle Bentué-Ferrer; Cédric Arvieux; Olivier Tribut; Annick Ruffault; Eric Bellissant
Clinical pharmacology, efficacy and safety of atazanavir: a review.
Expert opinion on drug metabolism & toxicology 2009;5(11):1455-68.
2009: Hélène Maby-El Hajjami; Patricia Ame-Thomas; Céline Pangault; Olivier Tribut; John DeVos; Rachel Jean; Nadège Bescher; Céline Monvoisin; Joëlle Dulong; Thierry Lamy; Thierry Fest; Karin Tarte
Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase.
Cancer research 2009;69(7):3228-37.
2009: Caroline Barau; Carlos Frangie; Cécile Goujard; Olivier Tribut; François Parant; Anne-Marie Taburet; Antoine Durrbach; Valérie Furlan
Falsely elevated whole blood tacrolimus concentrations due to interference in an affinity column-mediated immunoassay method on Xpand dimension.
Therapeutic drug monitoring 2009;31(2):267-8.
2008: Pierre Tattevin; Anne Maillard; Olivier Tribut; Emilie Saïkali; Cedric Arvieux; Christian Michelet
Undetectable HIV-1 viral load in the fluid of bullous skin lesion in a patient receiving highly active antiretroviral therapy.
International journal of STD & AIDS 2008;19(5):357-8.
2007: Anne Maillard; Jean-Marc Chapplain; Olivier Tribut; Danièle Bentué-Ferrer; Pierre Tattevin; Cédric Arvieux; Christian Michelet; Annick Ruffault
The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir-ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;38(2):131-8.
2006: B Cagnard; D Tosoni-Verlingue; Olivier Tribut; C Moizard; Laure Bridoux-Henno; N Delaperriere; Danièle Bentue-Ferrer; Alain Dabadie
[Advantages of different dosages of active metabolites in the follow-up of azathioprine treatment for Crohn disease].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 2006;13 Suppl 1():S67-8.
2006: Eric Dailly; Olivier Tribut; Pierre Tattevin; Cédric Arvieux; Philippe Perré; François Raffi; Pascale Jolliet
Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients.
European journal of clinical pharmacology 2006;62(7):523-6.
2005: Pierre-Nicolas d'Halluin; Olivier Tribut; Bernard Branger; Christine Lebreton; Jean-François Bretagne; Danièle Bentue-Ferrer; Denis Heresbach
RBC 6-TGN and hematological parameters in patients with Crohn's disease treated by azathioprine.
Gastroentérologie clinique et biologique 2005;29(12):1264-9.
2005: Olivier Tribut; Marie-Clémence Verdier; Cédric Arvieux; Hervé Allain; Christian Michelet; Danièle Bentué-Ferrer
Simultaneous quantitative assay of atazanavir and 6 other HIV protease inhibitors by isocratic reversed-phase liquid chromatography in human plasma.
Therapeutic drug monitoring 2005;27(3):265-9.
2005: Olivier Tribut; Jean-Michel Gaulier; Hervé Allain; Danièle Bentué-Ferrer
Major discrepancy between digoxin immunoassay results in a context of acute overdose: a case report.
Clinica chimica acta; international journal of clinical chemistry 2005;354(1-2):201-3.
2005: Anita Lucas-Girot; Marie-Clémence Verdier; Olivier Tribut; Jean-Christophe Sangleboeuf; Hervé Allain; Hassane Oudadesse
Gentamicin-loaded calcium carbonate materials: comparison of two drug-loading modes.
Journal of biomedical materials research. Part B, Applied biomaterials 2005;73(1):164-70.
2005: Cédric Arvieux; Olivier Tribut
Amprenavir or fosamprenavir plus ritonavir in HIV infection: pharmacology, efficacy and tolerability profile.
Drugs 2005;65(5):633-59.
2005: Pierre Tattevin; Olivier Tribut; Cédric Arvieux; M Dupont; R Flicoteaux; L Desbordes; Yves Le Tulzo; Christian Michelet
Use of high-performance liquid chromatography (HPLC) to monitor beta-lactam plasma concentrations during the treatment of endocarditis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(1):76-9.
2004: Yves Le Tulzo; Céline Pangault; Laurence Amiot; Valérie Guilloux; Olivier Tribut; Cédric Arvieux; Christophe Camus; Renée Fauchet; Rémi Thomas; Bernard Drénou
Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock.
American journal of respiratory and critical care medicine 2004;169(10):1144-51.
2004: Patrick Latour; Arnaud Biraben; Elisabeth Polard; Danièle Bentué-Ferrer; Anne Beauplet; Olivier Tribut; Hervé Allain
Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?
Human psychopharmacology 2004;19(3):193-203.
2003: Hervé Allain; Danièle Bentué-Ferrer; Olivier Tribut; S Gauthier; Bernard-François Michel; Christophe Drieu-La Rochelle
Alzheimer's disease: the pharmacological pathway.
Fundamental & clinical pharmacology 2003;17(4):419-28.
2003: Hervé Allain; Danièle Bentué-Ferrer; Olivier Tribut; Marc Mérienne; Serge Belliard
Drug therapy of frontotemporal dementia.
Human psychopharmacology 2003;18(3):221-5.
2003: Danièle Bentué-Ferrer; Olivier Tribut; Elisabeth Polard; Hervé Allain
Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.
CNS drugs 2003;17(13):947-63.
2003: Hervé Allain; Danièle Bentue-Ferrer; Olivier Tribut; Jean-François Pinel
Drugs and vascular dementia.
Dementia and geriatric cognitive disorders 2003;16(1):1-6.
2002: Yves Le Tulzo; Céline Pangault; Arnaud Gacouin; Valérie Guilloux; Olivier Tribut; Laurence Amiot; Pierre Tattevin; Rémi Thomas; Renée Fauchet; Bernard Drénou
Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome.
Shock (Augusta, Ga.) 2002;18(6):487-94.
2002: Olivier Tribut; Cédric Arvieux; Christian Michelet; Jean-Marc Chapplain; Hervé Allain; Danièle Bentué-Ferrer
Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography.
Therapeutic drug monitoring 2002;24(4):554-62.
2002: Olivier Tribut; Yvon Lessard; Jean-Michel Reymann; Hervé Allain; Danièle Bentué-Ferrer
Pharmacogenomics.
Medical science monitor : international medical journal of experimental and clinical research 2002;8(7):RA152-63.
2002: Cédric Arvieux; Pierre Tattevin; Faouzi Souala; Philippe Jaccard; Annick Ruffault; Danièle Bentué-Ferrer; Olivier Tribut; Jean-Marc Chapplain; Mathieu Dupont; Cécile Bouvier; Christian Michelet
Salvage therapy with amprenavir and ritonavir: prospective study in 17 heavily pretreated patients.
HIV clinical trials 2002;3(2):125-32.
2001: Hervé Allain; Olivier Tribut; Jean-Michel Reymann; Elisabeth Polard; P Lecavorzin; Danièle Bentue-Ferrer
[Perspectives for drug treatment in Alzheimer's disease].
Annales de médecine interne 2001;152(8):527-32.
2001: Hervé Allain; G Galesne; A Fresnel; Olivier Tribut; Franck Le Duff; Stéphane Schück; Philippe Le Cavorzin; N Mauduit; Pierre Le Beux
[An experience in teaching pharmacology on the internet].
Presse médicale (Paris, France : 1983) 2001;30(21):1065-70.
2001: Danièle Bentué-Ferrer; Jean-Michel Reymann; Olivier Tribut; Hervé Allain; E Vasar; Michel Bourin
Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(1):41-50.